The epidermal growth factor receptor (EGF-R) plays an important role in development and cell differentiation, and homologues of EGF-R have been identified in a broad range of vertebrate and invertebrate organisms. This work concerns the functional characterization of SER, the EGF-R-like molecule previously identified in the helminth parasite Schistosoma mansoni The epidermal growth factor receptor (EGF-R) 1 is a major key mediator of cell communication during animal development and homeostasis. EGF-R was the first receptor tyrosine kinase to be cloned (1), and its structure and activation pathways have been studied extensively. EGF-R represents the archetype of receptor tyrosine kinase with an extracellular ligand-binding part with two cysteine-rich repeats and an intracellular domain containing tyrosine kinase activity (2). In mammals, four isoforms of EGF-R have been characterized (EGF-R/ErbB-1, HER2/ErbB-2, HER3/ErbB-3, and HER4/ ErbB-4), and a number of different ligands, including epidermal growth factor (EGF)-like molecules, can selectively bind each isoform (3). Ligand binding activates the receptor by inducing the formation of homo-heterodimers. Dimerization triggers trans-phosphorylation and subsequent autophosphorylation of receptor molecules on tyrosine residues that provide docking sites for diverse effector and adaptor proteins. These partners (Grb2/Sos, p85-PI3K, PLC␥, and JAK) are active in different signal transduction cascades, such as the mitogenactivated protein kinase (MAPK), phosphoinositol 3-kinase, antiapoptotic kinase Akt, and several transcriptional regulatory pathways (reviewed in Ref. 4). Different homodimer-heterodimer combinations formed by EGF-R family members drive a complex signaling network within the MAPK pathway. The ERK pathway is the most recurrent and is mainly responsible for the mitogenic action of EGF receptors. Dysregulation of EGF-R signaling is therefore strongly oncogenic, and the direct implication of EGF-R isoforms in various cancers has been widely demonstrated. For this reason, EGF-R currently represents one of the major drug targets in human cancer therapy (5).In invertebrates, EGF-R isoforms appeared to be expressed in more limited numbers. A single isoform has been characterized in Caenorhabditis elegans (LET-23) (6) as well as in Drosophila melanogaster (DER) (7,8). A single cognate ligand (LIN-3) would be present in the worm (9), and four distinct cognate ligands (Vein, Gurken, Spitz, and Argos) would be present in the fly (10). These observations indicated that the EGF-R signaling module has grown in complexity from invertebrates to mammals. However, except for C. elegans and D. melanogaster models, few data are available at present about the role of the EGF-R family in invertebrate development.SER, the Schistosoma mansoni EGF-R homologue, is one of the three receptor tyrosine kinases that have been characterized in this trematode parasite (11,12). SER is present predominantly in schistosome muscles, suggesting that it could

The complexification of cell to cell interactions along metazoan evolution has led to the development of a molecular network specialized in intercellular communication. Receptor tyrosine kinases (RTKs) are among the most ancient and important proteins that emerged in multicellular organisms. RTKs form a superfamily of transmembrane receptors that bind a large panel of ligands including hormones, growth factors and cytokines, and trigger different signalling cascades inside the cell for the control and regulation of key cellular processes. In eumetazoan organisms, RTK mediation is essential for embryogenesis [1,2], growth [3] and metabolic regulations [4]. RTK diversity increased along with speciation, possibly due to the acquisition of new regulatory processes in cell function, so that conserved and original classes of RTK could be found in different metazoan organisms [5][6][7]. RTKs possess a unique transmembrane domain and their capacity to transduce signals inside the cell is dependent on their autophosphorylation and requires vicinity of two tyrosine kinase (TK) domains. Members of the insulin receptor (IR) family belong to the very well conserved RTK class II, and were probably present in the most ancient metazoans because they have been identified in diploblastic organisms like sponge [8]. Although most of the RTK are monomeric and dimerize upon ligand binding, IR are constitutively assembled in a 2 b 2 heterotetramers [9,10]. Binding of insulin peptides

Three in one: Native chemical ligation (NCL) and bis(2‐sulfanylethyl)amido (SEA) ligation allow the one‐pot assembly of three peptide segments in the N‐to‐C direction. The SEA group (see picture, blue) is switched off by intramolecular disulfide bond formation during NCL. Then, a phosphine switches it on to trigger the second SEA ligation step. The K1 domain of the hepatocyte growth factor was synthesized and found to be biologically active.

Insulin-stimulated glucose uptake requires the fusion of GLUT4 transporter-containing vesicles with the plasma membrane, a process that depends on the SNARE (soluble N-ethylmaleimide-sensitive fusion factor attachment receptor) proteins VAMP2 (vesicleassociated membrane protein 2) and syntaxin 4 (Stx4)͞SNAP23 (soluble N-ethylmaleimide-sensitive fusion factor attachment protein 23). Efficient SNARE-dependent fusion has been shown in many settings in vivo to require the generation of both phosphatidylinositol-4,5-bisphosphate (PIP2) and phosphatidic acid (PA). Addition of PA to Stx4͞SNAP23 vesicles markedly enhanced the fusion rate, whereas its addition to VAMP2 vesicles was inhibitory. In contrast, addition of PIP2 to Stx4͞SNAP23 vesicles inhibited the fusion reaction, and its addition to VAMP2 vesicles was stimulatory. The optimal distribution of phospholipids was found to trigger the progression from the hemifused state to full fusion. These findings reveal an unanticipated dependence of SNARE complex-mediated fusion on asymmetrically distributed acidic phospholipids and provide mechanistic insights into the roles of phospholipase D and PIP kinases in the late stages of regulated exocytosis.SNAP23 ͉ syntaxin 4 ͉ VAMP2

No abstract

The juxtamembrane domain of vesicle-associated membrane protein (VAMP) 2 (also known as synaptobrevin2) contains a conserved cluster of basic/hydrophobic residues that may play an important role in membrane fusion. Our measurements on peptides corresponding to this domain determine the electrostatic and hydrophobic energies by which this domain of VAMP2 could bind to the adjacent lipid bilayer in an insulin granule or other transport vesicle. Mutation of residues within the juxtamembrane domain that reduce the VAMP2 net positive charge, and thus its interaction with membranes, inhibits secretion of insulin granules in ␤ cells. Increasing salt concentration in permeabilized cells, which reduces electrostatic interactions, also results in an inhibition of insulin secretion. Similarly, amphipathic weak bases (e.g., sphingosine) that reverse the negative electrostatic surface potential of a bilayer reverse membrane binding of the positively charged juxtamembrane domain of a reconstituted VAMP2 protein and inhibit membrane fusion. We propose a model in which the positively charged VAMP and syntaxin juxtamembrane regions facilitate fusion by bridging the negatively charged vesicle and plasma membrane leaflets.

Cytosine-phosphate-guanine (CpG) motifs in bacterial DNA are known to activate the mammalian immune system, and this activation is thought to depend on the Toll-like receptor 9 (TLR9) signaling pathway. Previous studies strongly suggested that TLR9 is involved as the specific receptor for CpG motifs but did not provide direct evidence of their interaction. In this study, we demonstrate for the first time that murine TLR9 binds an unmethylated CpG-containing plasmid. This interaction is sequence-specific and is influenced by the methylation status of the plasmid. Furthermore, we demonstrate that this interaction leads to the activation of the NF-B pathway in mTLR9-expressing cells. Our results provide a molecular basis for the interaction between CpG-DNA and TLR9.

Small ubiquitin-like modifier (SUMO) post-translational modification (PTM) of proteins has a crucial role in the regulation of important cellular processes. This protocol describes the chemical synthesis of functional SUMO-peptide conjugates. The two crucial stages of this protocol are the solid-phase synthesis of peptide segments derivatized by thioester or bis(2-sulfanylethyl)amido (SEA) latent thioester functionalities and the one-pot assembly of the SUMO-peptide conjugate by a sequential native chemical ligation (NCL)/SEA native peptide ligation reaction sequence. This protocol also enables the isolation of a SUMO SEA latent thioester, which can be attached to a target peptide or protein in a subsequent step. It is compatible with 9-fluorenylmethoxycarbonyl (Fmoc) chemistry, and it gives access to homogeneous, reversible and functional SUMO conjugates that are not easily produced using living systems. The synthesis of SUMO-peptide conjugates on a milligram scale takes 20 working days.